-
1 Comment
Tianjin MOTIMO Membrane Technology Co.,Ltd is currently in a long term uptrend where the price is trading 18.4% above its 200 day moving average.
From a valuation standpoint, the stock is 23.0% cheaper than other stocks from the Industrials sector with a price to sales ratio of 3.9.
Tianjin MOTIMO Membrane Technology Co.,Ltd's total revenue rose by 10.2% to $138M since the same quarter in the previous year.
Its net income has increased by 118.3% to $16M since the same quarter in the previous year.
Finally, its free cash flow grew by 112.9% to $11M since the same quarter in the previous year.
Based on the above factors, Tianjin MOTIMO Membrane Technology Co.,Ltd gets an overall score of 5/5.
| Sector | Industrials |
|---|---|
| ISIN | CNE100001HF7 |
| Exchange | SHE |
| CurrencyCode | CNY |
| Industry | Specialty Industrial Machinery |
| Market Cap | 2B |
|---|---|
| Beta | 0.67 |
| PE Ratio | 152.0 |
| Target Price | 22.75 |
| Dividend Yield | None |
Tianjin MOTIMO Membrane Technology Co.,Ltd engages in the research and development, manufacture, and sale of ultra- and micro filtration membranes, membrane modules, and membrane equipment. The company also provides membrane replacement, membrane engineering, and sewage treatment operation and technical services, as well as membrane system integration solutions. In addition, it offers technical support and after-sales service. The company was founded in 1974 and is headquartered in Tianjin, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300334.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
